CAL-5-REVIVE- calcium balance liquid Estados Unidos - inglês - NLM (National Library of Medicine)

cal-5-revive- calcium balance liquid

vitality works, inc. - aconitum napellus (unii: u0nq8555jd) (aconitum napellus - unii:u0nq8555jd), bismuth subnitrate (unii: h19j064ba5) (bismuth cation - unii:zs9cd1i8ye), calcium arsenate (unii: 95ox15i8zu) (arsenate ion - unii:g1dbi405ok), calcium hydroxide (unii: pf5dzw74vn) (hydroxide ion - unii:9159uv381p), calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), calcium iodide (unii: 8eki9qee2h) (calcium cation - unii:2m83c4r6zb), calcium oxalate monohydrate (unii: 4pp86kk527) (calcium cation - unii:2m8 - aconitum napellus 20 [hp_x] in 1 ml

PARA-BN- parathyroid booster liquid Estados Unidos - inglês - NLM (National Library of Medicine)

para-bn- parathyroid booster liquid

vitality works, inc. - alfalfa (unii: djo934brbd) (alfalfa - unii:djo934brbd), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), sodium tetrachloroaurate (unii: 7ft6qut299) (tetrachloroaurate ion - unii:znl6ip5pjx), calcium hydroxide (unii: pf5dzw74vn) (hydroxide ion - unii:9159uv381p), calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), calcium iodide (unii: 8eki9qee2h) (calcium cation - unii:2m83c4r6zb), calcium oxalate monohydrate (unii: 4pp86kk527) (calcium cation - unii:2m8 - alfalfa 7 [hp_x] in 1 ml

CALCAREA CAUSTICA pellet Estados Unidos - inglês - NLM (National Library of Medicine)

calcarea caustica pellet

rxhomeo private limited d.b.a. rxhomeo, inc - calcium hydroxide (unii: pf5dzw74vn) (hydroxide ion - unii:9159uv381p) - backache condition listed above or as directed by the physician

CALCIUM ACETATE capsule Estados Unidos - inglês - NLM (National Library of Medicine)

calcium acetate capsule

hikma pharmaceuticals usa inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c: calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown.

CALCIUM ACETATE capsule Estados Unidos - inglês - NLM (National Library of Medicine)

calcium acetate capsule

remedyrepack inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and d

CALCIUM ACETATE capsule Estados Unidos - inglês - NLM (National Library of Medicine)

calcium acetate capsule

lupin pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unk

CALCIUM ACETATE capsule Estados Unidos - inglês - NLM (National Library of Medicine)

calcium acetate capsule

lupin limited - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1) ]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are un

CALCIUM ACETATE- calcium acetate capsule Estados Unidos - inglês - NLM (National Library of Medicine)

calcium acetate- calcium acetate capsule

ncs healthcare of ky, inc dba vangard labs - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c: calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1 ) ]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown

CALCIUM CHLORIDE injection, solution Estados Unidos - inglês - NLM (National Library of Medicine)

calcium chloride injection, solution

american regent, inc. - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - calcium chloride 100 mg in 1 ml - calcium chloride is indicated in the immediate treatment of hypocalcemic tetany.  other therapy, such as parathyroid hormone or vitamin d, may be indicated according to the etiology of the tetany. it is also important to institute oral calcium therapy as soon as practicable. calcium salts have been used as adjunctive therapy in a number of conditions, including the following: - insect bites or stings, such as black widow spider bites. sensitivity reactions, particularly when characterized by urticaria. as an aid in the treatment of depression due to overdosage of magnesium sulfate. as an aid in the management of the acute symptoms in lead colic. in cardiac resuscitation, particularly after open heart surgery, calcium chloride has been used when epinephrine has failed to improve weak or ineffective myocardial contractions. insect bites or stings, such as black widow spider bites. sensitivity reactions, particularly when characterized by urticaria. as an aid in the treatment of depression due to overdo

CALCIUM CHLORIDE injection, solution Estados Unidos - inglês - NLM (National Library of Medicine)

calcium chloride injection, solution

hospira, inc. - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - calcium chloride 100 mg in 1 ml - calcium chloride injection is indicated for the treatment of adult and pediatric patients with acute symptomatic hypocalcemia. limitations of use the safety and effectiveness of calcium chloride injection for long-term use has not been established. calcium chloride injection is contraindicated in: newborns (up to 28 days of age) if they require (or are expected to require) ceftriaxone intravenous treatment because of the risk of precipitation of ceftriaxone-calcium, regardless of whether these products would be received at different times or through separate intravenous lines [see warnings and precautions (5.1)] .       risk summary administration of calcium chloride injection for the treatment of acute symptomatic hypocalcemia during pregnancy is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. there are risks to the mother and the fetus associated with development of hypocalcemia during pregnancy (see clinical considerations) . animal reproduction studies have n